| Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi E Choy, VK Chiu, J Silletti, M Feoktistov, T Morimoto, D Michaelson, ... Cell 98 (1), 69-80, 1999 | 978 | 1999 |
| Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial P Schöffski, S Chawla, RG Maki, A Italiano, H Gelderblom, E Choy, ... The Lancet 387 (10028), 1629-1637, 2016 | 773 | 2016 |
| Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study S Chawla, R Henshaw, L Seeger, E Choy, JY Blay, S Ferrari, J Kroep, ... The lancet oncology 14 (9), 901-908, 2013 | 611 | 2013 |
| Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum Q Dai, E Choy, V Chiu, J Romano, SR Slivka, SA Steitz, S Michaelis, ... Journal of Biological Chemistry 273 (24), 15030-15034, 1998 | 436 | 1998 |
| Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial S George, Q Wang, MC Heinrich, CL Corless, M Zhu, JE Butrynski, ... Journal of Clinical Oncology 30 (19), 2401, 2012 | 288 | 2012 |
| Genetic analysis of human traits in vitro: drug response and gene expression in lymphoblastoid cell lines E Choy, R Yelensky, S Bonakdar, RM Plenge, R Saxena, PL De Jager, ... PLoS genetics 4 (11), e1000287, 2008 | 287 | 2008 |
| MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration Z Duan, E Choy, D Harmon, X Liu, M Susa, H Mankin, F Hornicek Molecular cancer therapeutics 10 (8), 1337-1345, 2011 | 273 | 2011 |
| The role of the CD58 locus in multiple sclerosis PL De Jager, C Baecher-Allan, LM Maier, AT Arthur, L Ottoboni, ... Proceedings of the National Academy of Sciences 106 (13), 5264-5269, 2009 | 238 | 2009 |
| NCCN guidelines insights: soft tissue sarcoma, version 1.2021: featured updates to the NCCN guidelines M von Mehren, JM Kane, MM Bui, E Choy, M Connelly, S Dry, KN Ganjoo, ... Journal of the National Comprehensive Cancer Network 18 (12), 1604-1612, 2020 | 224 | 2020 |
| Programmed cell death ligand 1 expression in osteosarcoma JK Shen, GM Cote, E Choy, P Yang, D Harmon, J Schwab, GP Nielsen, ... Cancer immunology research 2 (7), 690-698, 2014 | 199 | 2014 |
| Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels D Reich, N Patterson, V Ramesh, PL De Jager, GJ McDonald, A Tandon, ... The American Journal of Human Genetics 80 (4), 716-726, 2007 | 193 | 2007 |
| Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma IF Ciernik, A Niemierko, DC Harmon, W Kobayashi, YL Chen, TI Yock, ... Cancer 117 (19), 4522-4530, 2011 | 184 | 2011 |
| Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study S Chawla, JY Blay, P Rutkowski, A Le Cesne, P Reichardt, H Gelderblom, ... The Lancet Oncology 20 (12), 1719-1729, 2019 | 183 | 2019 |
| PICASSO III: a phase III, placebo-controlled study of doxorubicin with or without palifosfamide in patients with metastatic soft tissue sarcoma CW Ryan, O Merimsky, M Agulnik, JY Blay, SM Schuetze, BA Van Tine, ... Journal of Clinical Oncology 34 (32), 3898-3905, 2016 | 179 | 2016 |
| Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma M Susa, AK Iyer, K Ryu, E Choy, FJ Hornicek, H Mankin, L Milane, ... PloS one 5 (5), e10764, 2010 | 175 | 2010 |
| Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy E Choy, JE Butrynski, DC Harmon, JA Morgan, S George, AJ Wagner, ... BMC cancer 14, 1-6, 2014 | 168 | 2014 |
| Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor–associated tumors: results of a multicenter phase 2 trial AJ Wagner, JM Goldberg, SG DuBois, E Choy, L Rosen, A Pappo, ... Cancer 118 (23), 5894-5902, 2012 | 168 | 2012 |
| MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer X Yang, AK Lyer, A Singh, E Choy, FJ Hornicek, MM Amiji, Z Duan Scientific reports 5 (1), 8509, 2015 | 148 | 2015 |
| Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series JT Mullen, TF DeLaney, WK Kobayashi, J Szymonifka, BY Yeap, YL Chen, ... Annals of surgical oncology 19, 4028-4035, 2012 | 143 | 2012 |
| β‐Catenin mutation status and outcomes in sporadic desmoid tumors JT Mullen, TF DeLaney, AE Rosenberg, L Le, AJ Iafrate, W Kobayashi, ... The oncologist 18 (9), 1043-1049, 2013 | 134 | 2013 |
Mark Reid PhilipsNYU School of MedicineVerified email at nyu.edu
